186 related articles for article (PubMed ID: 15221296)
21. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
22. The utility of two somatostatin analog radiopharmaceuticals in assessment of radiologically indeterminate pulmonary lesions.
Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Saranovic DZ; Jaksic ED; Subotic D; Nagorni-Obradovic L; Kozarevic N; Petrovic N; Grozdic IT; Obradovic VB
Clin Nucl Med; 2012 Jan; 37(1):14-20. PubMed ID: 22157022
[TBL] [Abstract][Full Text] [Related]
23. Soft tissue metastases and lung cancer recurrence detected by Tc-99m depreotide scintigraphy.
Miliziano JS; Bradley YC
Clin Nucl Med; 2002 Jun; 27(6):410-2. PubMed ID: 12045431
[TBL] [Abstract][Full Text] [Related]
24. Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET.
Ferran N; Ricart Y; Lopez M; Martinez-Ballarin I; Roca M; Gámez C; Carrerea D; Guirao S; Leon AF; Martin-Comin J
Nucl Med Commun; 2006 Jun; 27(6):507-14. PubMed ID: 16710105
[TBL] [Abstract][Full Text] [Related]
25. 99mTc-Depreotide chest SPECT demonstrates pulmonary metastases from renal cell carcinoma.
Shih WJ; Romero RA; Timothy M; Milan PP
J Nucl Med Technol; 2004 Mar; 32(1):19-21. PubMed ID: 14990670
[TBL] [Abstract][Full Text] [Related]
26. Contribution of (99m)Tc-depreotide (Neospect) scintigraphy in lung cancer staging.
Karathanos E; Datseris I; Vlontzou E; Zisimopoulos A; Georgiou E
J BUON; 2010; 15(1):147-52. PubMed ID: 20414943
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide.
Menda Y; Kahn D
Semin Nucl Med; 2002 Apr; 32(2):92-6. PubMed ID: 11965604
[TBL] [Abstract][Full Text] [Related]
28. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules.
Blum J; Handmaker H; Lister-James J; Rinne N
Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805
[TBL] [Abstract][Full Text] [Related]
29. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT.
Naalsund A; Maublant J
Respiration; 2006; 73(5):634-41. PubMed ID: 16679755
[TBL] [Abstract][Full Text] [Related]
30. [Technetium99 labelled synthetic somatostatin analogue (depreotide) in the diagnosis of peripheral solitary pulmonary nodules].
Chciałowski A; Dziuk E; From S; Płusa T; Lubiński W; Pietrzykowski J; Zabicka M; Hussain N
Pol Arch Med Wewn; 2004 Sep; 112(3):1031-8. PubMed ID: 15727084
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
[TBL] [Abstract][Full Text] [Related]
32. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
33. Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging.
Wang F; Wang Z; Yao W; Xie H; Xu J; Tian L
J Nucl Med; 2007 Sep; 48(9):1442-8. PubMed ID: 17704242
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of somatostatin receptors in large cell pulmonary neuroendocrine carcinoma with 99mTc-EDDA/HYNIC-TOC scintigraphy.
Nocuń A; Chrapko B; Gołębiewska R; Stefaniak B; Czekajska-Chehab E
Nucl Med Commun; 2011 Jun; 32(6):522-9. PubMed ID: 21383640
[TBL] [Abstract][Full Text] [Related]
35. [The advantages of depreotide in the diagnosis of spherical solitary pulmonary nodules (SPN): preliminary study].
Chciałowski A; Drabek I; From S; Płusa T; Dziuk E; Hussein N
Pol Merkur Lekarski; 2003 Mar; 14(81):185-8. PubMed ID: 12914090
[TBL] [Abstract][Full Text] [Related]
36. The value of HRCT and Tc-depreotide in the evaluation of pulmonary lesions.
Rasmussen K; Madsen HH; Rasmussen F; Rasmussen TR; Baandrup U; Pilegaard HK; Pedersen U; Palshof T; Rehling M
J Thorac Oncol; 2006 May; 1(4):296-301. PubMed ID: 17409873
[No Abstract] [Full Text] [Related]
37. [Clinical usefulness of 99mTc-PMT whole body scans in the diagnosis of bone metastases from hepatocellular carcinoma].
Nakanishi Y; Ha-Kawa SK
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Feb; 52(2):208-16. PubMed ID: 1313962
[TBL] [Abstract][Full Text] [Related]
38. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D
J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698
[TBL] [Abstract][Full Text] [Related]
39. Discrepant uptake between 111In-pentetreotide and 99mTc-MDP in bone metastases of small-cell lung cancer.
Meristoudis G; Ilias I; Giannakopoulos V; Batsakis C; Christakopoulou J
Hell J Nucl Med; 2009; 12(3):283-4. PubMed ID: 19936347
[No Abstract] [Full Text] [Related]
40. Accumulation of Tc-99m depreotide (NeoSpect) in axillary sweat glands.
Danielsson R; Bååth M; Kölbeck KG; Klominek J; Svensson L
Clin Nucl Med; 2003 Sep; 28(9):789-90. PubMed ID: 12973013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
